Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials (International non-profit association)
Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 1013.225.475. It was founded on 05-09-2024. Its registered office is in Anderlecht. Its main activity is: Human health activities.
Information last updated on 07-10-2026.
Company information
Similar companies
Other companies in the same activity in Anderlecht.
| Company | Town |
|---|---|
| CARDIO 2000 | 1070 Anderlecht |
| CERBA HEALTHCARE BELGIUM | 1070 Anderlecht |
| C.O.A.L. | 1070 Anderlecht |
| TANDARTSEN VOSSEN - MERTENS | 1070 Anderlecht |
| LAUTHEMI | 1070 Anderlecht |
| ZEKHNINI MEDI-CARE | 1070 Anderlecht |
| ENDOGAST | 1070 Anderlecht |
| CENTRE DE PREVENTION DENTAIRE - GUY COTTON | 1070 Anderlecht |
Frequently asked questions
Is Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials still active? Yes. The Crossroads Bank for Enterprises lists Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials as active.
What is the VAT number of Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials? The VAT number of Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials is BE 1013.225.475.
When was Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials founded? Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials was founded on 05-09-2024.
What is the address of Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials? The current registered office of Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials is Rue Meylemeersch 90, 1070 Anderlecht.
Can Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials receive Peppol e-invoices? Yes. Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials is registered on the Peppol network and can receive structured electronic invoices.
What does Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials do? The main activity of Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials is: Human health activities.